BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25716338)

  • 1. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.
    Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J
    Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/β-Catenin Pathway.
    Wang Y; Yang Q; Cheng Y; Gao M; Kuang L; Wang C
    Med Sci Monit; 2018 Dec; 24():9110-9119. PubMed ID: 30552850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
    Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
    Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
    Han J; Shen X; Zhang Y; Wang S; Zhou L
    Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
    Zhang L; Liu H; Mu X; Cui J; Peng Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Growth Factor Promotes Proliferation and Migration of Follicular Outer Root Sheath Cells via Wnt/β-Catenin Signaling.
    Zhang H; Nan W; Wang S; Zhang T; Si H; Yang F; Li G
    Cell Physiol Biochem; 2016; 39(1):360-70. PubMed ID: 27352380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.
    Chen X; Hu W; Xie B; Gao H; Xu C; Chen J
    Biochem Biophys Res Commun; 2014 May; 448(2):206-11. PubMed ID: 24785374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
    Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
    Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SUMO1P3 promotes glioma progression via the Wnt/β-catenin pathway.
    Lou JY; Luo J; Yang SC; Ding GF; Liao W; Zhou RX; Qiu CZ; Chen JM
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9571-9580. PubMed ID: 33015800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer.
    Tong W; Sun D; Wang Q; Suo J
    Cell Biochem Biophys; 2015 Jun; 72(2):453-9. PubMed ID: 25567655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
    Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
    Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
    Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.